For decades, Penn researchers and clinicians have been nationally recognized leaders in understanding the causes of lung cancer, mesothelioma and related disorders, and in finding more effective forms of treatment.
Lung cancer specialists at Penn Medicine also care for patients with cancer of the trachea (airway), mediastinum (mid-chest), pleura (lining of the lung) and other areas of the thorax (chest cavity).
A Multidisciplinary Approach to Care
The best treatments for lung cancer and other malignancies of the chest require a highly multidisciplinary approach that includes care from medical, surgical and radiation oncologists, interventional pulmonologists and radiologists, pathologists, as well as ancillary clinicians, including nurse practitioners, counselors, psychiatrists, nutritionists and other support staff specializing in the care of patients with lung cancer.
Penn medical oncologists administer systemic treatments, usually in the form of chemotherapy as well as newer targeted agents, and coordinate the complex care required for patients with lung cancer.
Penn surgeons, interventional pulmonologists, interventional radiologists and pathologists are experts in the diagnosis of lung cancer. Penn radiologists interpret imaging studies to determine whether and where any cancer has spread.
Medical oncologists are part of a treatment team that also includes surgical and radiation oncologists, pulmonologists and diagnostic radiologists, who meet every week to review patient cases and discuss treatment plans in detail ensuring that patients get treatment options from all disciplines and that care is optimized.
Patients with lung cancer who come to Penn also receive support from staff at the Abramson Cancer Center, a National Cancer Institute (NCI) designated comprehensive cancer care center rated as "exceptional" after its most recent peer review.
Services for Lung Cancer
Medical oncology services for lung cancer at Penn include:
- A dedicated clinical trials staff specializing in the treatment of all stages of lung cancer.
- Multiple clinical trials for all stages of lung cancer, including studies of:
- Radiation therapy
- Targeted molecular therapy
- Vaccine and immunologic therapy
- Individualized treatment approaches that include the pathological analysis of tumor material in order to personalize medical treatments.
- Palliative care services
The Penn Difference
- Penn's lung cancer, mesothelioma and related disorders research program is conducting important clinical trials, ensuring that the latest scientific discoveries are translated into better patient care.
- Penn Medicine provides Oncology Navigation Specialists, education, events and support groups through the Abramson Cancer Center, a NCI-designated comprehensive cancer center.
- Penn hematologists and oncologists are engaged in a broad range of basic and clinical research, clinical care and teaching.
- Penn hematologists and oncologists are national and international leaders in developing and testing new therapies for cancer treatment.
Types of Lung Cancer and Related Diseases Treated at Penn Medicine
- Non-small cell lung cancer
- Pulmonary carcinoid
- Small cell lung cancer
- Thymic tumors
Lung Cancer Physicians and Team
Penn hematologists/oncologists that specialize in lung cancer include:
Today, more and more people are surviving cancer. It is because of clinical trials, many of which are conducted at Penn Medicine, that patients are benefiting from breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day, giving patients hope that even greater discoveries lie ahead.